References
- Clauss A. Gerinnungsphysiologische schnellmeth-ode zur bestimmung des fibrinogens. Acta Haematol. 1957; 17: 237
- Dige-Petersen H., Lassen N. A., Noer I., Tønnesen K. H. Subclinical ergotism. Lancet 1977; i: 65
- Dormandy J. A., Goyle K. B., Reid H. L. Treatment of severe intermittent claudication by controlled defibrination. Lancet 1977; i: 625
- Dormandy J. A., Hoare E., Colley J., Arrowsmith D. E., Dormandy T. L. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Brit. med. J. 1973; iv: 576
- Ehringer H., Dudezak E., Lechner K. Thera-peutische defibrinierung mit ancrod. Ein neues konzept der behandlung periferen arterieller durch-blutungsstörungen. Dtsch. med. Wschr. 1973; 98: 2298
- Gormsen J. Fibrinolytic activity and haemagglutin-ation inhibition immunoassays. Scand. J. Haematol. 1970; 7: 261
- Holleman W. H., Coen L. J. Characterization of peptides released from human fibrinogen by Arwin. Biochim. biophys. Acta 1970; 200: 587
- Holstein P., Krähenbuhl B., Lassen N. A. Induzierte hypertonie in der behandlung peripherer arterieller krankheit. Hypertonie: Risikofaktor in der Angiologie., E. Zeitler. Verlag Gerhard Witzstrock, Baden-Baden 1976; 157
- Lassen N. A., Tønnesen K. H., Holstein P. Editorial, Distal blood pressure. Scand. J. clin. Lab. Invest. 1976; 36: 705
- Lauersen B., Gormsen J. Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity. Scand. J. Haematol. 1969; 6: 402
- Strandness D. E., Bell J. W. Peripheral vascular disease: diagnosis and objective evaluation using a mercury strain gauge. Ann. Surg. 1965; 161: 3, Suppl. 4